Table 3. Biochemical tests among diabetic patients based on different tertiles of the adherence to the Nordic dietary pattern scores (N = 339) .
| Variables | All | Nordic diet adherence | P value a | ||
| Low | Medium | High | |||
| FBS (mg/dL) | |||||
| Crude model | 111.24 ± 33.45 | 118.71 ± 35.77 | 110.22 ± 28.71 | 110.16 ± 37.69 | 0.304 |
| Model 1 | 119.77 ± 95.17 | 110.12 ± 48.23 | 109.93 ± 52.83 | 0.214 | |
| Model 2 | 118.11 ± 94.62 | 111.07 ± 48.05 | 109.30 ± 52.65 | 0.327 | |
| SBP (mm Hg) | |||||
| Crude model | 127.71 ± 17.50 | 130.95 ± 12.79 | 127.28 ± 18.83 | 127.22 ± 17.11 | 0.441 |
| Model 1 | 131.04 ± 49.89 | 127.32 ± 25.22 | 127.14 ± 27.61 | 0.423 | |
| Model 2 | 130.55 ± 50.07 | 127.79 ± 25.04 | 126.86 ± 27.79 | 0.499 | |
| DBP (mm Hg) | |||||
| Crude model | 127.71 ± 11.95 | 86.66 ± 11.45 | 82.83 ± 9.90 | 84.50 ± 14.08 | 0.146 |
| Model 1 | 86.21 ± 33.50 | 82.91 ± 16.93 | 84.55 ± 18.59 | 0.209 | |
| Model 2 | 86.09 ± 33.87 | 83.04 ± 17.30 | 84.45 ± 18.77 | 0.290 | |
| TG (mg/dL) | |||||
| Crude model | 151.78 ± 76.91 | 163.33 ± 71.41 | 140.28 ± 69.99 | 161.99 ± 84.67 | 0.031 |
| Model 1 | 161.76 ± 217.97 | 140.32 ± 110.46 | 162.42 ± 121.13 | 0.032 | |
| Model 2 | 155.18 ± 209.50 | 144.53 ± 106.59 | 159.79 ± 116.35 | 0.202 | |
| HDL (mg/dL) | |||||
| Crude model | 42.32 ± 9.70 | 41.71 ± 7.87 | 42.16 ± 8.95 | 42.70 ± 11.03 | 0.812 |
| Model 1 | 41.31 ± 26.69 | 42.10 ± 13.43 | 42.89 ± 14.72 | 0.587 | |
| Model 2 | 41.69 ± 26.51 | 41.88 ± 13.43 | 43.07 ± 14.72 | 0.499 | |
| LDL (mg/dL) | |||||
| Crude model | 94.17 ± 30.98 | 102.81 ± 29.51 | 93.98 ± 32.13 | 91.71 ± 29.73 | 0.127 |
| Model 1 | 99.98 ± 83.76 | 94.24 ± 42.34 | 92.29 ± 46.39 | 0.338 | |
| Model 2 | 99.38 ± 84.31 | 94.75 ± 42.89 | 91.98 ± 46.76 | 0.354 | |
| TC (mg/dL) | |||||
| Crude model | 181.53 ± 46.49 | 179.79 ± 33.59 | 185.84 ± 45.79 | 176.91 ± 50.42 | 0.249 |
| Model 1 | 177.02 ± 129.97 | 185.94 ± 65.90 | 177.64 ± 72.16 | 0.235 | |
| Model 2 | 176.24 ± 130.89 | 186.13 ± 66.46 | 178.04 ± 72.71 | 0.235 | |
| AST (mg/dL) | |||||
| Crude model | 32.64 ± 5.93 | 36.14 ± 6.56 | 32.88 ± 5.89 | 31.26 ± 5.29 | < 0.0001 |
| Model 1 | 36.23 ± 16.20 | 32.86 ± 8.28 | 31.26 ± 9.02 | < 0.0001 | |
| Model 2 | 36.25 ± 16.38 | 32.76 ± 8.28 | 31.41 ± 9.02 | < 0.0001 | |
| hs-CRP | |||||
| Crude model | 2.96 ± 0.50 | 2.91 ± 0.52 | 2.99 ± 0.48 | 2.94 ± 0.51 | 0.602 |
| Model 1 | 2.91 ± 1.28 | 2.99 ± 0.55 | 2.94 ± 0.73 | 0.589 | |
| Model 2 | 2.91 ± 1.28 | 2.99 ± 0.73 | 2.94 ± 0.73 | 0.507 | |
| Fibrinogen | |||||
| Crude model | 247.30 ± 18.82 | 246.43 ± 14.56 | 248.40 ± 20.44 | 246.27 ± 18.01 | 0.594 |
| Model 1 | 246.39 ± 53.94 | 248.42 ± 27.24 | 246.26 ± 29.82 | 0.586 | |
| Model 2 | 246.12 ± 54.30 | 248.23 ± 27.61 | 246.41 ± 30.19 | 0.663 | |
Abbreviations: FBS: fasting blood sugar; SBP & DBP: systolic and diastolic blood pressure; TG: triglyceride; HDL & LDL: high and low-density lipoprotein; TC: total cholesterol; AST: aspartate trance aminase; hs-CRP: high sensitive-C reactive protein.
Data presented as mean ± SD.
a P values presented resulted from ANCOVA analysis and in crude model, model 1 which adjusted for sex and age, and model 2 which adjusted for model 1 + energy intake, and BMI.